Quantcast

Latest Thoratec Stories

2014-07-21 16:26:19

PLEASANTON, Calif., July 21, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter of fiscal year 2014 on Wednesday, August 6. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2014-07-02 16:24:45

PLEASANTON, Calif., July 2, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has acquired Apica Cardiovascular Limited ("Apica") for an upfront cash payment of $35 million and potential future clinical and sales milestones of up to $40 million. As part of the agreement, the Apica team based at facilities in Ireland and the United States will...

2014-06-27 08:25:53

PLEASANTON, Calif., June 27, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE Mark Clinical Trial for HeartMate III(TM) commenced with the first patient implanted with this new device. "We are pleased to reach this significant clinical milestone with an important pipeline product," said Gary F. Burbach, President and Chief Executive...

2014-06-13 23:01:37

In-demand research report “Australia Cardiovascular Devices Market Outlook to 2020” worked out by GlobalData is now available at MarketPublishers.com. London, UK (PRWEB) June 13, 2014 Presently, cardiac diseases are highly prevalent among people in Australia and worldwide and are associated with substantial mortality and morbidity. Therefore, it is not surprising that the development of various cardiovascular devices presents an area of intensive scientific and clinical research...

2014-06-05 23:16:07

On April 1, the FDA announced that the previous recall of HeartMate II LVAS Pocket System Controller, by Thoratec Corporation, was classified as Class I. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 05, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for HeartMate II LVAS Pocket...

2014-06-03 23:02:45

In-demand research report “Japan Cardiovascular Devices Market Outlook to 2020” worked out by GlobalData is now available at MarketPublishers.com. London, UK (PRWEB) June 03, 2014 Cardiovascular diseases are common in Asia. It is the major cause of death in such countries as Japan, China and India. Around 60% of the world’s total number of deaths (17.3 million) occur in the Asian region. Unfortunately, this number is poised to increase in the years to come. However, the growing...

2014-06-03 08:32:48

PLEASANTON, Calif., June 3, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in three upcoming investor conferences. On Tuesday, June 10, the company will participate in the Goldman Sachs 35(th) Annual Global Healthcare Conference. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the...

2014-05-29 12:25:40

Heart Failure Remains an Area of Focus for Physicians, Facilities and Manufacturers, According to Findings from Decision Resources Group BURLINGTON, Mass., May 29, 2014 /PRNewswire/ -- Decision Resources Group finds that the U.S. cardiac assist device market has gained traction in recent years with product innovations, particularly among ventricular assist devices (VADs), commonly known in the media as LVADs. There are currently limited treatment options for patients with acute heart failure...

2014-05-06 16:32:47

-Revenue of $125.7 million for the first quarter of 2014 PLEASANTON, Calif., May 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, today reported its financial results for the first quarter of 2014. "Our operational and financial progress in the first quarter provides a solid foundation for a successful 2014," said Gary F. Burbach, President and...

2014-05-01 08:34:24

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/w5x8m7/global_remote) has announced the addition of the "Global Remote Patient Monitoring Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Remote patient monitoring is a technology that enables the monitoring of patients outside clinics and hospitals. Remote patient monitoring provides a remote interface that gathers and transfers regular patient...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related